Comparative Study of Mortality and Morbidity in Premature Infants (Birth Weight, <1,250 g) with Candidemia or Candidal Meningitis
+ Author Affiliations
- Reprints or correspondence: Dr. J. Robinson, Department of Pediatrics, 2C300 Walter C. Mackenzie Health Sciences Center, Edmonton, Alberta, Canada T6G 2R7.
Abstract
Little information is available on long-term neurodevelopment of premature neonates with invasive candidal infections. We retrospectively studied the outcomes for 25 premature neonates (birth weight, <1,250 g) with candidemia or candidal meningitis (cases) and compared them with 25 neonates matched for birth weight (±100 g) and gestational age (±1 week) (controls). Durations of antibiotic therapy, artificial ventilation, invasive catheterizations, and hyperalimentation were longer for cases than for controls. Cases had a higher final grade of intraventricular hemorrhage than did controls (median: 3.0 vs. 2.5, respectively; P < .05). Forty-four percent (11 of 25) of cases and 16% (4 of 25) of controls died (P > .05), and 29% (4 of 14) of surviving cases and 14% (3 of 21) of controls were disabled (P > .05). More cases had combined mortality and neurodevelopmental disabilities than did controls (60% vs. 28%, respectively; P < .05). Use of invasive therapies should be minimized for premature neonates at risk for invasive candidal infection that is associated with adverse outcomes.
- Received January 5, 1998.
- Revision received May 1, 1998.
- © 1998 by the Infectious Diseases Society of America
No comments:
Post a Comment